As seen in www.healthinsights.ca. There are 80,000 Canadians living with bladder cancer, and many of them are younger than you’d think. Here’s one family’s story about why awareness and early detection are critical in saving lives. “On Nov. 27th, 2020, I lost my husband and father to our three-year-old daughter to metastatic bladder cancer. JohnRead more
Blog
Bladder Cancer Canada (BCC) is seeking an Executive Director for our national charity. Leading with a passion for BCC’s mission and vision that motivates and engages others, the new Executive Director will take our near $1M charity to the next level by building and diversifying our fundraising revenue, allowing us to expand our vital programsRead more
Wearing a mask in public spaces during COVID has been a challenge for so many of us. But for Cathy, who reads lips to communicate with others, it’s muted the world around her. Cathy, who lost her much of hearing at the age of 18 months because of spinal meningitis, has learned to overcome herRead more
Our March newsletter reflects our mission – patient support, awareness and research. BCC was founded in 2009 to support bladder cancer patients and their loved ones. Supporting you at every step of this journey remains a cornerstone of our mission, with “support” coming in many forms to help meet your individual needs. By way ofRead more
TORONTO, CANADA (May 15, 2020) – This year, 12,000 Canadians will be diagnosed with bladder cancer, and for many of these Canadians, the global development of COVID-19 will impact bladder cancer diagnoses, treatments and outcomes. With hospitals experiencing a delay in cancer-related surgeries and treatments, and access to healthcare teams being limited, now, more thanRead more
Uncertain times are upon us, around the world, as we globally respond to the coronavirus (COVID-19) that is affecting us all on some level. Many members of our bladder cancer community are directing questions our way about how the this virus might affect their health and treatments. We will be answering many of these questions after consulting with theRead more
Dearest Friend, Uncertain times are upon us, around the world, as we globally respond to the coronavirus (COVID-19) that’s affecting us all on some level. For those of you diagnosed with bladder cancer, undergoing treatment, waiting for surgeries or trying to move forward with your lives post-cancer, we know that this can be an especiallyRead more
Dear Friend of Bladder Cancer Canada,Please help us understand what patients and caregivers think is important in bladder cancer research.Below is a link to a patient and caregiver survey that has been designed by our colleagues at the Bladder Cancer Advocacy Network in the USA. This survey has already been completed by many across the USA and we areRead more
(The following content is sourced from various sites advising on the coronavirus. For more information, please see the end of this article for additional resources. Photo Credit: CDC) As news of the coronavirus (COVID-19) continues to spread globally, many people have become concerned about contracting this disease. For cancer patients and survivors that have a compromisedRead more
In a recent press release, Janssen Pharmaceutical Companies of Johnson & Johnson have announced that they have received approval from Health Canada for BALVERSA™ (erdafitinib), the first FGFR Kinase inhibitor for the treatment of patients with locally advanced or metastatic urothelial carcinoma with certain FGFR genetic alterations. Health Canada has approved the therapy on the conditionRead more
